在前列腺癌中通过增强元件调节雄激素受体表达
Sudeep Khadka1,2, Hee-Young Jeon1,2, Arif Hussain1,2,3
1Department of Biochemistry and Molecular Biology, University of Maryland, Baltimore, MD, USA.
Experimental & molecular medicine
|January 16, 2026
概括
雄激素受体 (AR) 的过度表达驱动了割抵抗性前列腺癌 (CRPC). 了解AR基因放大和增强元件对于识别CRPC中的新治疗点至关重要.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 雄激素受体 (AR) 过度表达是割抵抗性前列腺癌 (CRPC) 进展的关键驱动因素.
- 机制包括增强的AR转录和增加的AR mRNA/蛋白质稳定性.
- 在AR位点的基因放大是临床CRPC样本中AR过度表达的重要原因.
研究的目的:
- 在CRPC中调查增强剂元素在AR过度表达中的作用.
- 通过增强剂探索AR基因调节的机制.
- 根据AR信号来确定CRPC的潜在治疗点.
主要方法:
- 在CRPC样本中分析AR基因位点和相关的调控元素.
- 通过增强剂-促进剂循环来研究增强剂-促进剂相互作用.
- 与增强剂活性相关的AR转录和蛋白质水平的评估.
主要成果:
- 在AR位点的基因放大导致AR转录和蛋白质水平升高.
- 增强AR基因附近增强剂元素的活性或拷贝数量的增加增强了AR转录.
- 增强元件通过循环与AR基因促进体相互作用,以促进AR mRNA转录.
结论:
- 由AR过度表达驱动的异常AR信号是CRPC发展的核心.
- 增强剂元素在推动CRPC中AR过度表达方面发挥着重要作用.
- 针对这些增强元件是CRPC的一种有前途的治疗策略.
更多相关视频
13:19Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
Published on: November 2, 2013
17.1K
09:07Prediction and Validation of Gene Regulatory Elements Activated During Retinoic Acid Induced Embryonic Stem Cell Differentiation
Published on: June 21, 2016
8.6K
相关概念视频
RNA Polymerase II Accessory Proteins
10.8K
Proteins that regulate transcription can do so either via direct contact with RNA Polymerase or through indirect interactions facilitated by adaptors, mediators, histone-modifying proteins, and nucleosome remodelers. Direct interactions to activate transcription is seen in bacteria as well as in some eukaryotic genes. In these cases, upstream activation sequences are adjacent to the promoters, and the activator proteins interact directly with the transcriptional machinery. For example, in...
10.8K
Master Transcription Regulators
7.7K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.7K
Epigenetic Regulation
33.5K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
33.5K
Epigenetic Regulation
3.7K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.7K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Regulation of Angiogenesis and Blood Supply
3.3K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.3K
